Dr. Cheng-Hsuan Wu

About

Assisted reproduction institutions in Taiwan are reviewed periodically by the Ministry of Health and Welfare, and the items on those reviews cover laboratory standards, medical records, gamete and embryo donation procedures and patient safety. Dr. Cheng-Hsuan Wu has sat on the committee side of that exercise as an evaluator of ART institutions, which is the least ordinary background a fertility physician brings, and the reason the deputy director’s chair at NUWA Fertility Center comes with an unusual vantage point. A second oversight post sits next to it: reviewer for the National Health Insurance Administration’s hospital medical service review.

The clinical foundation is in central and southern Taiwan’s teaching hospitals. The medical degree came from the School of Medicine at Kaohsiung Medical University and the doctorate from the Institute of Medicine at Chung Shan Medical University. Between those, Dr. Wu directed the reproductive medical center at Changhua Christian Hospital, a major central Taiwan teaching hospital, and held an assistant professorship in the obstetrics and gynecology department at Kaohsiung Medical University — a unit leadership post and a ministry-established faculty title held at the same time, which is the combination that pushes a physician’s judgment toward published guidelines rather than local habit.

At NUWA the position is Deputy Medical Director of Reproductive Medicine and Attending Physician, and the work behind it has a clear center of gravity: IVF, IUI and egg freezing as the treatment services; infertility examination as the entry point; recurrent miscarriage, PGT-A and hysteroscopy as the cluster that handles what happens when transfers do not work; and endometriosis and polycystic ovary syndrome as the underlying conditions that most often produce that pattern.

Clinical Expertise

• IVF: stimulation protocol, monitoring, retrieval, culture and transfer managed as one sequence, with dose and timing individualized rather than standardized across patients.
• IUI: induced ovulation combined with processed insemination into the uterine cavity, used as the level of help before laboratory fertilization is warranted.
• Recurrent miscarriage: losses examined as a set rather than one at a time, with embryo chromosome status, uterine cavity structure, endocrine control and immune contribution each considered before the next attempt is planned.
• PGT-A: screening embryos for abnormal chromosome number, a decision that turns on maternal age, how many oocytes a cycle yields and what previous transfers produced, and which carries the risk of no eligible embryo being found.
• Hysteroscopic surgery: the camera passed through the cervix to remove polyps and open adhesions, so a cavity problem is settled before another attempt is made rather than discovered by another failed cycle.
• Endometriosis: judged by effect on ovarian reserve and implantation, with the sequencing of surgery against stimulation treated as the central question rather than a routine step.
• Polycystic ovary syndrome: ovulation induction where response varies widely between patients, so dose titration and hyperstimulation monitoring are part of the cycle design.
• Egg freezing: oocytes banked by vitrification before a pregnancy is deferred, with the practical ceiling set by how many mature eggs one retrieval yields.

Why Choose Dr. Wu

Experience inspecting fertility institutions rather than only working in one. Membership of the ministry’s evaluation committee for assisted reproduction institutions means reading other clinics’ laboratory records, cycle documentation and donation procedures against a published standard. For a patient who wants to know what a clinic’s laboratory quality claim actually rests on, that is the more informative background than a society membership, and the same applies to the health insurance administration’s service review post, which covers what Taiwan’s payment rules will and will not fund in a cycle.

A hospital reproductive center under direction. The Changhua Christian Hospital appointment is unit-level responsibility for a service’s medical operation rather than only for a personal patient list, and the assistant professorship in obstetrics and gynecology at Kaohsiung Medical University adds the faculty side of the same field. A doctorate from the Institute of Medicine at Chung Shan Medical University sits underneath both, which is why the practice reads as guideline-led.

The difficult trio handled in one consultation. Recurrent miscarriage, PGT-A and hysteroscopy are practiced together here, alongside endometriosis and PCOS, which is the combination a repeated-loss patient needs: chromosome screening of embryos, correction of the cavity, and treatment of the underlying disease argued in a single plan rather than in three separate referrals.

Professional Affiliations

Society and institutional roles: supervisor of the Taiwanese Society for Reproductive Medicine, and supervising physician within the training system of the Taiwan Association for Minimally Invasive Gynecology, the latter matching the hysteroscopic side of the practice. Government service runs alongside it: evaluator for the Ministry of Health and Welfare’s committee reviewing assisted reproduction institutions, and reviewer for the National Health Insurance Administration’s hospital medical service review.

Clinical and academic posts: deputy medical director of reproductive medicine and attending physician at NUWA Fertility Center; head of the reproductive medical center at Changhua Christian Hospital; assistant professor, department of obstetrics and gynecology, Kaohsiung Medical University. Degrees: Ph.D., Institute of Medicine, Chung Shan Medical University; School of Medicine, Kaohsiung Medical University.

Suitable For

Recurrent miscarriage needing a full workup: causes in this group are spread across embryo, cavity, hormones and immunity, and investigating only one of them tends to produce another loss rather than an answer. Screening, cavity surgery and disease management are covered in one practice, so the branches can be examined within one framework.

Deciding whether PGT-A applies: screening is not automatic, since it depends on age, expected oocyte yield and previous cycle results, and it changes both the timeline and the cost of a treatment. A physician who also reviews institutional standards can say where the laboratory’s screening process stops short.

Endometriosis or PCOS alongside infertility: both alter the stimulation plan, one by damaging the ovarian environment and the other by making drug response unpredictable, and both need the sequencing of treatment and conception decided together.

Uterine cavity treated before transfer: polyps, adhesions and irregular cavity shape lower the chance per transfer, so correcting them first avoids spending a cycle on an unrevised uterus.

Patients asking about laboratory standards: most clinics answer that question with a general assurance. Committee experience in institutional evaluation makes it possible to say which items the national review actually inspects, and therefore what a quality claim should be verifiable against.